These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 23024165)

  • 1. Searching for uremic toxins.
    Dobre M; Meyer TW; Hostetter TH
    Clin J Am Soc Nephrol; 2013 Feb; 8(2):322-7. PubMed ID: 23024165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uremic toxicity: urea and beyond.
    Depner TA
    Semin Dial; 2001; 14(4):246-51. PubMed ID: 11489197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short dialysis, middle molecules, and uremia.
    Nolph KD
    Ann Intern Med; 1977 Jan; 86(1):93-7. PubMed ID: 835933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of isohydric hemodialysis on the binding and removal of uremic retention solutes.
    Etinger A; Kumar SR; Ackley W; Soiefer L; Chun J; Singh P; Grossman E; Matalon A; Holzman RS; Meijers B; Lowenstein J
    PLoS One; 2018; 13(2):e0192770. PubMed ID: 29470534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The removal of uremic toxins.
    Dhondt A; Vanholder R; Van Biesen W; Lameire N
    Kidney Int Suppl; 2000 Aug; 76():S47-59. PubMed ID: 10936799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracorporeal removal of uremic toxins: can we still do better?
    Eloot S; Ledebo I; Ward RA
    Semin Nephrol; 2014 Mar; 34(2):209-27. PubMed ID: 24780474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro Removal of Protein-Bound Retention Solutes by Extracorporeal Blood Purification Procedures.
    Schildboeck C; Harm S; Hartmann J
    Blood Purif; 2024; 53(4):231-242. PubMed ID: 38262384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classification of Uremic Toxins and Their Role in Kidney Failure.
    Rosner MH; Reis T; Husain-Syed F; Vanholder R; Hutchison C; Stenvinkel P; Blankestijn PJ; Cozzolino M; Juillard L; Kashani K; Kaushik M; Kawanishi H; Massy Z; Sirich TL; Zuo L; Ronco C
    Clin J Am Soc Nephrol; 2021 Dec; 16(12):1918-1928. PubMed ID: 34233920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of hemodialysis duration on the removal of uremic retention solutes.
    Eloot S; Van Biesen W; Dhondt A; Van de Wynkele H; Glorieux G; Verdonck P; Vanholder R
    Kidney Int; 2008 Mar; 73(6):765-70. PubMed ID: 18160958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPLC study of uremic fluids related to optical dialysis adequacy monitoring.
    Lauri K; Tanner R; Jerotskaja J; Luman M; Fridolin I
    Int J Artif Organs; 2010 Feb; 33(2):96-104. PubMed ID: 20306436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein-bound uremic solutes: the forgotten toxins.
    Vanholder R; De Smet R; Lameire N
    Kidney Int Suppl; 2001 Feb; 78():S266-70. PubMed ID: 11169024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing the removal of protein-bound uremic toxins by liposome-supported hemodialysis.
    Shi Y; Wang Y; Ma S; Liu T; Tian H; Zhu Q; Wang W; Li Y; Ding F
    Artif Organs; 2019 May; 43(5):490-503. PubMed ID: 30375673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavior of non-protein-bound and protein-bound uremic solutes during daily hemodialysis.
    Fagugli RM; De Smet R; Buoncristiani U; Lameire N; Vanholder R
    Am J Kidney Dis; 2002 Aug; 40(2):339-47. PubMed ID: 12148107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Approaches to uremia.
    Meyer TW; Hostetter TH
    J Am Soc Nephrol; 2014 Oct; 25(10):2151-8. PubMed ID: 24812163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obstacles to reducing plasma levels of uremic solutes by hemodialysis.
    Sirich TL
    Semin Dial; 2017 Sep; 30(5):403-408. PubMed ID: 28558415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uremic toxins: a new focus on an old subject.
    Yavuz A; Tetta C; Ersoy FF; D'intini V; Ratanarat R; De Cal M; Bonello M; Bordoni V; Salvatori G; Andrikos E; Yakupoglu G; Levin NW; Ronco C
    Semin Dial; 2005; 18(3):203-11. PubMed ID: 15934967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional genomic analysis identifies indoxyl sulfate as a major, poorly dialyzable uremic toxin in end-stage renal disease.
    Jhawar S; Singh P; Torres D; Ramirez-Valle F; Kassem H; Banerjee T; Dolgalev I; Heguy A; Zavadil J; Lowenstein J
    PLoS One; 2015; 10(3):e0118703. PubMed ID: 25811877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uremia: A historical reappraisal of what happened
.
    Raghavan R; Eknoyan G
    Clin Nephrol; 2018 May; 89(5):305-313. PubMed ID: 29451473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical and clinical evidence for uremic toxicity.
    Bouré T; Vanholder R
    Artif Organs; 2004 Mar; 28(3):248-53. PubMed ID: 15046622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. More of the same: improving outcomes through intensive hemodialysis.
    McFarlane PA
    Semin Dial; 2009; 22(6):598-602. PubMed ID: 20017828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.